Lingge Yang
Impact in
-
- Sarcoma Diagnosis and Treatment
- Ferroptosis and cancer prognosis
-
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Vascular Tumors and Angiosarcomas
Papers in
- Oncology 12
- Lung Cancer Research Studies 3
- Cancer Immunotherapy and Biomarkers 3
- Cutaneous Melanoma Detection and Management 2
- Peptidase Inhibition and Analysis 2
-
- Sarcoma Diagnosis and Treatment 4
- Lung Cancer Treatments and Mutations 3
- Ferroptosis and cancer prognosis 2
- Co-authors
- Chunmeng Wang (12 shared papers)Peng Luo (10 shared papers)Wangjun Yan (7 shared papers)Weiluo Cai (4 shared papers)Biqiang Zheng (3 shared papers)Shiqi Chen (2 shared papers)Zhengwang Sun (2 shared papers)Shiqi Chen (5 shared papers)
- Journals
- Frontiers in Oncology (4 papers)Cancer Management and Research (3 papers)Frontiers in Immunology (3 papers)International Journal of Clinical Oncology (2 papers)Genes (2 papers)
- Partner nations
- ChinaSwitzerlandUnited States
In The Last Decade
Lingge Yang
20 papers receiving 255 citations
Peers
Comparison fields: 5 of 38
- Pulmonary and Respiratory Medicine 133
- Oncology 83
- Cancer Research 29
- Immunology 42
- Rheumatology 21
Countries citing papers authored by Lingge Yang
This map shows the geographic impact of Lingge Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingge Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingge Yang more than expected).
Fields of papers citing papers by Lingge Yang
This network shows the impact of papers produced by Lingge Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingge Yang. The network helps show where Lingge Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingge Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 43 | |
| 2 | 2023 | 39 | |
| 3 | 2019 | 29 | |
| 4 | 2018 | 19 | |
| 5 | 2022 | 17 | |
| 6 | 2022 | 17 | |
| 7 | 2019 | 14 | |
| 8 | 2021 | 10 | |
| 9 | 2018 | 10 | |
| 10 | 2022 | 9 | |
| 11 | 2018 | 9 | |
| 12 | 2019 | 9 | |
| 13 | 2024 | 8 | |
| 14 | 2020 | 7 | |
| 15 | 2019 | 6 | |
| 16 | 2021 | 5 | |
| 17 | 2021 | 3 | |
| 18 | 2020 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2021 | 1 |
About Lingge Yang
Lingge Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cardiology and Cardiovascular Medicine and Rheumatology, having authored 23 papers that have together received 257 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (4 papers), Lung Cancer Research Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers), Ferroptosis and cancer prognosis (2 papers), Cutaneous Melanoma Detection and Management (2 papers), Peptidase Inhibition and Analysis (2 papers) and Cardiac tumors and thrombi (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (133 citations), Oncology (83 citations), Cancer Research (29 citations), Immunology (42 citations) and Rheumatology (21 citations). Lingge Yang has collaborated with scholars based in China, Switzerland and United States. Frequent co-authors include Chunmeng Wang, Peng Luo, Wangjun Yan, Weiluo Cai, Biqiang Zheng, Shiqi Chen, Zhengwang Sun, Shiqi Chen, Long Zhang and Wending Huang. Their work appears in journals such as Frontiers in Oncology, Cancer Management and Research, Frontiers in Immunology, International Journal of Clinical Oncology and Genes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.